All In MedTech

FDA Clearance Tracker · P140018-S018

VenaSeal Closure System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 25, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 25, 2020

Approved

Time to decision

89 days

Received Oct 28, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P140018-S018
Device name
VenaSeal Closure System
Applicant location
Plymouth, MN
Received
Oct 28, 2019
Decided
Jan 25, 2020
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P140018

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code PJQ

FDA's approval statement

As written in FDA's record.

Approval for an update to the instructions for use adding the option to deliver up to 3 aliquots of the device prior to compression.

Source documents

Other decisions for Medtronic Vascular, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.